Login / Signup

Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease.

Michihiro IwakiTakaomi KessokuAnna OzakiYuki KasaiTakashi KobayashiAsako NogamiYasushi HondaYuji OgawaKento ImajoMasato YonedaAyako MaedaYoshiki TanakaShunji NakajimaHiroshi OhnoHaruki UsudaMiwa KawanakaTakumi KawaguchiTakuji TorimuraMasayoshi KageHideyuki HyogoHirokazu TakahashiYuichiro EguchiShinichi AishimaKoichiro WadaNoritoshi KobayashiYoshio SumidaSatoru SaitoHirokazu Takahashi
Published in: Journal of gastroenterology and hepatology (2021)
The decrease in the abundance of Eubacterium that produces butyric acid may play an important role in the development of non-alcoholic fatty liver disease in non-obese individuals. This study was registered at the University Hospital Medical Information Network clinical trial registration system (UMIN000020917).
Keyphrases
  • obese patients
  • bariatric surgery
  • clinical trial
  • roux en y gastric bypass
  • gastric bypass
  • liver fibrosis
  • weight loss
  • healthcare
  • adipose tissue
  • type diabetes
  • open label
  • antibiotic resistance genes
  • social media